Long-term Care Software: US vs China

Market size, growth to 2033 and clinical trials, side by side.

The US is the bigger Long-term Care Software market: $1.5 Bn against $281 Mn in 2023, about 5.2 times as large.

China grows faster: 14.1% a year, against 10.6%. The gap still grows from $1.2 Bn to $3 Bn by 2033.

Clinical research: 133 active trials in the US, 57 in China.

Long-term Care Software: US compared with China
Measure US China
Market size, 2023$1.5 Bn$281 Mn
Market size, 2033 projected$4 Bn$1.1 Bn
Growth a year (CAGR)10.6%14.1%
Money added, 2023–2033$2.6 Bn$771 Mn
Share of the world market42%8%
Size rank of 24 countries#1#2
Market per person, 2023$4.30$0.20
Active clinical trials 133 57
Full reportUS report China report

Year by year, 2023 to 2033

US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.

Quick answers

Which is bigger in Long-term Care Software, US or China?

The US is the bigger Long-term Care Software market: $1.5 Bn against $281 Mn in 2023, about 5.2 times as large.

Which grows faster in Long-term Care Software, US or China?

China grows faster: 14.1% a year, against 10.6%. The gap still grows from $1.2 Bn to $3 Bn by 2033.

More Long-term Care Software comparisons

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.